SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
CODI reached a settlement with Lugano Debtors to support a liquidation plan, securing recoveries and resolving claims. This move allows CODI to focus ...
Palmer Square Capital BDC declared a supplemental dividend of $0.03 per share for Q2 2026, bringing the total quarterly payout to $0.39. This addition...
MillerKnoll reported fiscal year 2026 results with sales up 4.4% to $1 billion and Jeff Stutz appointed interim CEO. The market will likely view the l...
ICF International intends to release its second quarter 2026 financial results on August 6, 2026. The company will host a webcast conference call at 4...
Serina Therapeutics filed an amendment to its certificate of incorporation increasing authorized common shares to 125 million and preferred shares to ...
JPMorgan Chase released hypothetical 2026 Dodd-Frank Act Stress Test results for a nine-quarter period under a restrictive economic scenario. The comp...
Elicio Therapeutics is disclosing the clinical roadmap for ELI-002 7P in metastatic pancreatic ductal adenocarcinoma. The company outlines the planned...
Chewy entered into a Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The facility outlines the terms and structure for the co...
PIMCO Fund amended its prospectus to allow subprime and foreign loan investments, marking a significant strategic change....
The fund has amended its prospectus to permit direct lending and investment in subprime or unrated debt instruments, expanding its risk profile. This ...
The fund sold 961,171 common shares for $25.125 million via a private offering. This transaction highlights capital deployment efforts within the priv...
PIMCO High Income Fund amended its prospectus to allow investments in subprime loans and increase common stock limits to 20%. These modifications expa...
Micron Technology reported fiscal third quarter 2026 revenue of $41.46 billion and net income of $28.86 billion. The record results highlight the comp...
Indaptus Therapeutics entered into a definitive agreement to sell up to 20 million common shares at $0.60 per share, generating approximately $12 mill...
Wells Fargo Commercial Mortgage Securities entered a material definitive agreement on May 28, 2026, for the issuance of commercial mortgage debt. Inve...
Ionis Pharmaceuticals announced the FDA approval of olezarsen (Tryngolza), a new treatment for severe hypertriglyceridemia. This marks the company's f...
The registrant filed a Current Report on Form 8-K dated June 24, 2026. The text was truncated immediately upon the report of Item 8.01 Other Events, p...
Institutional holdings report (13F-HR) filed by Optimus Capital Advisors, LLC....
The Registrant entered into Transaction Documents related to the issuance of asset-backed securities by Ford Credit Auto Owner Trust 2026-B. This fili...
EFCAR transferred sub-prime automobile loan contracts to Exeter Automobile Receivables Trust 2026-3 in exchange for asset-backed notes worth $142M. Th...